Patent · US Active

Fused tricyclic urea compounds as Raf kinase and/or Raf kinase dimer inhibitors

US9670203B2 · kind B2 · utility

3Cited by
0References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 27, 2014
Grant dateJun 6, 2017
Priority date—
Expiry dateJun 27, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are certain fused tricyclic urea compounds and salts thereof, compositions thereof, and methods of use therefor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.